Skip to main content
. 2017 Sep 27;26(24):4916–4928. doi: 10.1093/hmg/ddx372

Figure 7.

Figure 7.

Altering the rate of aging affects (PR)50 but not (GR)50 toxicity. (A) Paralysis assay of animals expressing GFP, (GR)50 or (PR)50 under the control of the myo-3 promoter in the wild-type or daf-2(e1370) background. ‘Day 0’ animals were isolated as L4 stage animals. N = 48–50 animals per genotype. n.s., ‘not significant’; **P < 0.01 versus GFP control (Log-rank test with Bonferroni adjusted P-value). (B) Paralysis assay of animals expressing (PR)50 under the control of the myo-3 promoter in the wild-type, daf-16(mu86), or daf-2(e1370); daf-16(mu86) background. N = 48–50 animals per genotype. n.s., ‘not significant’; ***P < 0.001 versus (PR)50 (Log-rank test with Bonferroni adjusted P-value). (C) Paralysis assay of animals expressing (PR)50 under the control of the myo-3 promoter in the wild-type or hsf-1(sy441) mutant background. N = 48–50 animals per genotype. ***P < 0.001 versus wild-type (Log-rank test with Bonferroni adjusted P-value). (D) Fluorescent microscopy images of day 1 adult worms expressing either (GR)50 or (PR)50 (green) and soluble muscle mCherry (red) in the wild-type or daf-2(e1370) mutant background. Arrow points to site of nuclear DPR accumulation. Scale bar=10 μm. (E) Fluorescent microscopy images of Day 1 adult worms expressing (PR)50 (green) and soluble muscle mCherry (red) in the daf-16(mu86) or daf-2(e1370); daf-16(mu86) mutant background. Arrow points to site of nuclear DPR accumulation. Scale bar=10 μm . (F) Fluorescent microscopy images of day 1 adult worms expressing (PR)50 (green) and soluble muscle mCherry (red) in the wild-type or hsf-1(sy441) mutant background. Arrow points to site of nuclear DPR accumulation. Scale bar=10 μm.